A quick unofficial mid-quarter portfolio review (official quarterly reviews here). Views welcome.
Latest portfolio weightings below.
Tristel (TSTL): These shares have marched higher on no news, and the holding now represents 19% of my portfolio. Last time this position reached 19% was January 2016, and I top sliced… at 138p. Price now 670p. Still minded to run this winner.
HY results due a week Monday. Figures should be no surprise following the AGM. Same update hinted at favourable US progress. Outlook all important given my 19% position. Will last year’s extra pandemic sales be repeated? Rating now very elevated at over 50x. Written up my annual report notes here.
Bioventix (BVXP): No news. HY results due in March. Rating remains lofty at c33x. Written up my annual report notes here. 12% weighting means almost a third of my portfolio rests upon two healthcare-related stocks.
Mountview Estates (MTVW): No news, although mystery shareholders may have engaged with management.
S&U (SUS): Issued a promising full-year update. Company now seems to be looking beyond the pandemic with the chairman using upbeat adjectives. All feels encouraging. Should really have bought more of these last year. FY results due in March.
City of London Inv. (CLIG): Issued a mixed Q2 update. New clients remain elusive, but the shares have performed well YTD. HY results on Monday. Webinar set for Thursday. I hope to submit questions; some may be awkward.
FW Thorpe (TFW): No news. Written up my annual report notes here. HY results due in March
M Winkworth (WINK): Issued an encouraging statement, but the ending of the stamp-duty subsidy could curtail progress. Might spell a buying opportunity? Q4 dividend continues the recovering payout trend.
Mincon (MCON): No news but website has been revamped. FY results due in March.
Tasty (TAST): Not bankrupt just yet – shares in fact up 83% YTD. Bank facility news appears very positive, and implies Barclays views the restaurant chain’s future as ‘assured’. Offers of up to 40% off deliveries continue to land in my inbox. FY results due in March.
Overall, no major disasters just yet and fingers crossed for the bevy of results between now and the end of Q1.
How is your portfolio doing?